Superparamagnetic Iron Oxide Nanoparticles as a Tracer for Sentinel Lymph Node Mapping in Endometrial Cancer
International Journal of Molecular Sciences · 17.01.2025 · 26 (2) · 781
DOI: 10.3390/ijms26020781 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.01.2025. Verfasst von Marcin A Jedryka und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Wroclaw Medical University, 50-367 Wroclaw, Poland. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Sentinel Lymph Node, Magnetic Iron Oxide Nanoparticles, Sentinel Lymph Node Biopsy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Polish Ministry of Health, Sysmex Europe GmBH.
Abstract (Originalsprache)
Sentinel lymph node (SLN) detection has been widely investigated in recent years as a part of the surgical staging of women with endometrial cancer (EC), gradually overtaking lymphadenectomy (LND) in this respect. In this study, thirty EC patients, assumed as stage I, were investigated using superparamagnetic iron oxide (SPIO) as a tracer for SLN detection followed by LND. The endpoints of this research were the proportion of successful SLN detection, the average number of SLNs per patient, the percentage of bilaterally detected SLNs, and the proportion of metastatic SLNs. Safety endpoints were the summary of all reported adverse events. SLNs were detected in all cases and bilaterally in 21 patients (70%). The diagnostic accuracy parameters of the SPIO detection of metastatic SLNs evaluated by Receiver Operating Characteristic (ROC) curve analysis with the area under the ROC curve (AUC) demonstrated a sensitivity of 80% and AUC of 0.9 (p < 0.001), confirming the SPIO technique’s efficacy in women with EC. No adverse events were reported. SPIO nanoparticles as a tracer for SLN mapping in apparent early-stage EC patients demonstrated satisfactory accuracy parameters and safety; however, these data need to be evaluated by further research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Wroclaw Medical University, 50-367 Wroclaw, Poland.
- Department of Oncologic Gynecology, Lower Silesian Oncology, Pulmonology and Hematology Center, 53-413 Wroclaw, Poland.
- Department of Gynecology and Obstetrics, Provincial Specialist Hospital, 64-100 Leszno, Poland.
- Breast Cancer Clinic, Lower Silesian Oncology, Pulmonology and Hematology Center, 53-413 Wroclaw, Poland.
ORCID-Profile: Marcin A Jedryka, Andrzej Czekanski, Rafał Matkowski
Förderung
- Polish Ministry of Health
- Sysmex Europe GmBH
Zitieren
APA
Jedryka, M. A., Klimczak, P., Kryszpin, M., Poprawski, T., Czekanski, A., Lepka, P., & Matkowski, R. (2025). Superparamagnetic Iron Oxide Nanoparticles as a Tracer for Sentinel Lymph Node Mapping in Endometrial Cancer. International Journal of Molecular Sciences, 26(2), 781. https://doi.org/10.3390/ijms26020781
Vancouver
Jedryka MA, Klimczak P, Kryszpin M, Poprawski T, Czekanski A, Lepka P, et al. Superparamagnetic Iron Oxide Nanoparticles as a Tracer for Sentinel Lymph Node Mapping in Endometrial Cancer. International Journal of Molecular Sciences. 2025;26(2):781. doi:10.3390/ijms26020781
BibTeX
@article{Jedryka2025,
author = {Jedryka, Marcin A and Klimczak, Piotr and Kryszpin, Marcin and Poprawski, Tymoteusz and Czekanski, Andrzej and Lepka, Piotr and Matkowski, Rafał},
title = {Superparamagnetic Iron Oxide Nanoparticles as a Tracer for Sentinel Lymph Node Mapping in Endometrial Cancer},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {2},
pages = {781},
doi = {10.3390/ijms26020781}
}
EUVIMED